Asano M, Okada H, Itoh Y, Hirata H, et al. Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: A double-blind, randomized controlled phase 1/2 trial. Int J Infect Dis 2021 Oct 21. pii: S1201-9712(21)00818.
PMID: 34688944